Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Best Practice & Research. Clinical Haematology|July 13, 2010
Chronic lymphocytic leukaemia: a disease of activated monoclonal B cellsRajendra N Damle, Carlo Calissano, Nicholas Chiorazzi
Molecular Medicine (Cambridge, Mass.)|March 24, 2007
The CD38 ectoenzyme family: advances in basic science and clinical practiceFortunato Morabito, Rajendra N Damle, Silvia Deaglio, et al.
Blood|July 12, 2003
Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the cloneEmilia Albesiano, Bradley T Messmer, Rajendra N Damle, et al.
Blood|August 9, 2007
CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cellsRajendra N Damle, Sonal Temburni, Carlo Calissano, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
Biology and treatment of chronic lymphocytic leukemiaMichael J Keating, Nicholas Chiorazzi, Bradley Messmer, et al.
Blood|August 10, 2012
T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patientsRajendra N Damle, Sonal Temburni, Taraneh Banapour, et al.
British Journal of Haematology|March 30, 2011
CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cellsNino Porakishvili, Azka Memon, Ketki Vispute, et al.
Scientific Reports|August 10, 2022
Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancerDenise L Cecil, Benjamin Curtis, Ekram Gad, et al.
Molecular Medicine (Cambridge, Mass.)|January 23, 2015
Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like ReceptorNino Porakishvili, Ketki Vispute, Andrew J Steele, et al.
Blood|January 30, 2010
Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of originCharles C Chu, Rosa Catera, Lu Zhang, et al.
Pageof 3